Fixed-Dose Combinations in the Management of Hypertension

This publication has 25 references indexed in Scilit:

• Hydrochlorothiazide Versus Chlorthalidone
  Hypertension, 2004
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 Report
  JAMA, 2003
• Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
  JAMA, 2002
• Hypertension in high-risk patients: beware of the underuse of effective combination therapy (results of the PRATIK study)
  Journal Of Hypertension, 2002
• Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
  Published by Elsevier ,2002
• Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
  New England Journal of Medicine, 2001
• Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
  New England Journal of Medicine, 2001
• Area Postrema And Sympathetic Nervous System Effects Of Vasopressin And Angiotensin II
  Clinical and Experimental Pharmacology and Physiology, 2000
• Angiotensin receptor antagonism with losartan and the regression of left ventricular hypertrophy
  Journal of Human Hypertension, 1998
• Comparison of natriuretic, uricosuric, and antihypertensive properties of tienilic acid, bendrofluazide, and spironolactone.
  BMJ, 1979